Tolcapone

Tolcapone
Trade Name
Orphan Indication Hereditary ATTR amyloidosis
USA Market Approval USA
USA Designation Date 2013-12-24 00:00:00
Sponsor Corino Therapeutics, Inc.;57 West 57th Street, 18th Floor;New York, New York, 10019
Related Access Program
Alnylam Pharmaceuticals – Amyloidosis, Hereditary, Transthyretin-Related Alnylam Pharmaceuticals – Amyloid Neuropathies, Familial Alnylam Pharmaceuticals – Familial Amyloid Polyneuropathies Alnylam Pharmaceuticals – Familial amyloid polyneuropathy